BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8645619)

  • 1. Imidazole derivatives of pyrrolidonic and piperidonic as potential inhibitors of human placental aromatase in vitro.
    Baroudi M; Robert J; Luu-Duc C
    J Steroid Biochem Mol Biol; 1996 Jan; 57(1-2):73-7. PubMed ID: 8645619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationships of the inhibition of human placental aromatase by imidazole drugs including ketoconazole.
    Ayub M; Levell MJ
    J Steroid Biochem; 1988 Jul; 31(1):65-72. PubMed ID: 3398530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and aromatase inhibition of 3-cycloalkyl-substituted 3-(4-aminophenyl)piperidine-2,6-diones.
    Hartmann RW; Batzl C; Pongratz TM; Mannschreck A
    J Med Chem; 1992 Jun; 35(12):2210-4. PubMed ID: 1613747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the racemate and the enantiomers of a new highly active and selective aromatase inhibitor of the aminoglutethimide type.
    Hartmann RW; GrĂ¼n G; Bartz U; Palzer M
    J Steroid Biochem Mol Biol; 1992 Dec; 43(7):641-8. PubMed ID: 1472456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of imidazole based compounds as cytochrome P-450 inhibitors.
    Ahmed S; Smith JH; Nicholls PJ; Whomsley R; Cariuk P
    Drug Des Discov; 1995 Aug; 13(1):27-41. PubMed ID: 8882899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analogues of aminoglutethimide based on 1-phenyl-3-azabicyclo[3.1.0]hexane-2,4-dione: selective inhibition of aromatase activity.
    Rowlands MG; Bunnett MA; Foster AB; Jarman M; Stanek J; Schweizer E
    J Med Chem; 1988 May; 31(5):971-6. PubMed ID: 3361583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1-[(Benzofuran-2-yl)phenylmethyl]-triazoles and -tetrazoles - potent competitive inhibitors of aromatase.
    Vinh TK; Ahmadi M; Delgado PO; Perez SF; Walters HM; Smith HJ; Nicholls PJ; Simons C
    Bioorg Med Chem Lett; 1999 Jul; 9(14):2105-8. PubMed ID: 10450990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of estrogen synthetase (aromatase) by 4-cyclohexylaniline.
    Kellis JT; Vickery LE
    Endocrinology; 1984 Jun; 114(6):2128-37. PubMed ID: 6723577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analogues of 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione as selective inhibitors of aromatase: derivatives with variable 1-alkyl and 3-alkyl substituents.
    Leung CS; Rowlands MG; Jarman M; Foster AB; Griggs LJ; Wilman DE
    J Med Chem; 1987 Sep; 30(9):1550-4. PubMed ID: 3625703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The inhibitory effect of miconazole on aromatase activity for androstenedione in human placental and ovarian preparations].
    Yamamoto T; Urabe M; Okada H
    Nihon Naibunpi Gakkai Zasshi; 1987 Nov; 63(11):1379-85. PubMed ID: 3443212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacology of aminoglutethimide: structure/activity relationships and receptor interactions.
    Nicholls PJ; Daly MJ; Smith HJ
    Breast Cancer Res Treat; 1986; 7 Suppl():S55-67. PubMed ID: 3755630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and evaluation of 4-(4'-aminobenzyl)-2-oxazolidinones as novel inhibitors of the cytochrome P-450 enzyme aromatase.
    Ahmed S; Adat S; Murrells A; Owen CP; Amanuel Y
    Bioorg Chem; 2002 Oct; 30(5):315-31. PubMed ID: 12485592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biochemical evaluation of analogues of aminoglutethimide based on phenylpyrrolidine-2,5-dione.
    Daly MJ; Jones GW; Nicholls PJ; Smith HJ; Rowlands MG; Bunnett MA
    J Med Chem; 1986 Apr; 29(4):520-3. PubMed ID: 3754286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aromatase inhibitors--mechanisms for non-steroidal inhibitors.
    Vanden Bossche HV; Moereels H; Koymans LM
    Breast Cancer Res Treat; 1994; 30(1):43-55. PubMed ID: 7949204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of aromatase (P450Arom) by some 1-(benzofuran-2-ylmethyl)imidazoles.
    Owen CP; Nicholls PJ; Smith HJ; Whomsley R
    J Pharm Pharmacol; 1999 Apr; 51(4):427-33. PubMed ID: 10385215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and structure-activity relationships of 6-phenylaliphatic-substituted C19 steroids having a 1,4-diene, 4,6-diene, or 1,4,6-triene structure as aromatase inhibitors.
    Numazawa M; Yamaguchi S
    Steroids; 1999 Mar; 64(3):187-96. PubMed ID: 10400379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and in vitro evaluation of 3-(1-azolylmethyl)-1H-indoles and 3-(1-azolyl-1-phenylmethyl)-1H-indoles as inhibitors of P450 arom.
    Le Borgne M; Marchand P; Duflos M; Delevoye-Seiller B; Piessard-Robert S; Le Baut G; Hartmann RW; Palzer M
    Arch Pharm (Weinheim); 1997 May; 330(5):141-5. PubMed ID: 9237426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imidazole antimycotics: inhibitors of steroid aromatase.
    Mason JI; Murry BA; Olcott M; Sheets JJ
    Biochem Pharmacol; 1985 Apr; 34(7):1087-92. PubMed ID: 3921030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Additive effects of aminoglutethimide, testololactone, and 4-hydroxyandrostenedione as inhibitors of aromatase.
    Santner SJ; Rosen H; Osawa Y; Santen RJ
    J Steroid Biochem; 1984 Jun; 20(6A):1239-42. PubMed ID: 6748639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potency and specificity of CGS-16949A as an aromatase inhibitor.
    Santen RJ; Langecker P; Santner SJ; Sikka S; Rajfer J; Swerdloff R
    Endocr Res; 1990; 16(1):77-91. PubMed ID: 2139412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.